NCT01311557 - Study of Adacel® Vaccine Administered to Persons 10 Years of Age | Biotech Hunter

Enrollment

1,302

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

January 31, 2012

Conditions

TetanusDiphtheriaPertussis

Interventions

BIOLOGICAL

Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed

0.5 mL, Intramuscular

BIOLOGICAL

Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed

0.5 mL, Intramuscular

Trial Locations (34)

14609

Rochester

15241

Pittsburgh

22180

Vienna

23113

Midlothian

29812

Barnwell

30062

Marietta

30189

Woodstock

33141

Miami Beach

37660

Kingsport

40040

Bardstown

40202

Louisville

41017

Crestview Hills

42431

Madisonville

44121

Cleveland

54449

Marshfield

55441

Plymouth

57701

Rapid City

70006

Metairie

71037

Haughton

72205

Little Rock

72401

Jonesboro

76135

Fort Worth

78205

San Antonio

78705

Austin

80501

Longmont

84057

Orem

84095

South Jordan

84124

Salt Lake City

85224

Chandler

95816

Sacramento

99202

Spokane

06360

Norwich

01801

Woburn

02886

Warwick